Neuroepigenomics and Human Disease

John M. Greally, Eric J. Nestler

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There has been explosive growth in epigenetic research of the nervous system. Epigenetic regulatory processes are believed to mediate mechanisms through which environmental factors exert lifelong changes in the brain and its behavioral output. There is also the possibility that certain types of epigenetic modifications are passed onto offspring and influence their functioning through mechanisms that remain poorly understood. We provide a broader context for these neuroepigenomic questions by highlighting the range of epigenetic mechanisms that are employed by mammalian organisms and current technical challenges in their characterization, and how they contribute to understanding neurological and psychiatric diseases based on studies in animal models and humans. Although the field of neuroepigenomics holds considerable promise, major technical advances are needed to exploit the evolving knowledge for improved understanding of disease pathogenesis and improved therapeutics.

Original languageEnglish (US)
Title of host publicationGenomics, Circuits, and Pathways in Clinical Neuropsychiatry
PublisherElsevier Inc.
Pages73-91
Number of pages19
ISBN (Print)9780128001059
DOIs
StatePublished - Jun 21 2016

Fingerprint

Epigenomics
Genetic Epigenesis
Nervous System
Psychiatry
Animal Models
Brain
Growth
Research
Therapeutics

Keywords

  • Addiction
  • Chromatin
  • Depression
  • DNA methylation
  • Epigenetics
  • Histone acetylation
  • Histone methylation
  • Nucleosomes
  • Transcription

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Greally, J. M., & Nestler, E. J. (2016). Neuroepigenomics and Human Disease. In Genomics, Circuits, and Pathways in Clinical Neuropsychiatry (pp. 73-91). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800105-9.00005-6

Neuroepigenomics and Human Disease. / Greally, John M.; Nestler, Eric J.

Genomics, Circuits, and Pathways in Clinical Neuropsychiatry. Elsevier Inc., 2016. p. 73-91.

Research output: Chapter in Book/Report/Conference proceedingChapter

Greally, JM & Nestler, EJ 2016, Neuroepigenomics and Human Disease. in Genomics, Circuits, and Pathways in Clinical Neuropsychiatry. Elsevier Inc., pp. 73-91. https://doi.org/10.1016/B978-0-12-800105-9.00005-6
Greally JM, Nestler EJ. Neuroepigenomics and Human Disease. In Genomics, Circuits, and Pathways in Clinical Neuropsychiatry. Elsevier Inc. 2016. p. 73-91 https://doi.org/10.1016/B978-0-12-800105-9.00005-6
Greally, John M. ; Nestler, Eric J. / Neuroepigenomics and Human Disease. Genomics, Circuits, and Pathways in Clinical Neuropsychiatry. Elsevier Inc., 2016. pp. 73-91
@inbook{b30c85dc6d9440a3bf56c1fe8c436432,
title = "Neuroepigenomics and Human Disease",
abstract = "There has been explosive growth in epigenetic research of the nervous system. Epigenetic regulatory processes are believed to mediate mechanisms through which environmental factors exert lifelong changes in the brain and its behavioral output. There is also the possibility that certain types of epigenetic modifications are passed onto offspring and influence their functioning through mechanisms that remain poorly understood. We provide a broader context for these neuroepigenomic questions by highlighting the range of epigenetic mechanisms that are employed by mammalian organisms and current technical challenges in their characterization, and how they contribute to understanding neurological and psychiatric diseases based on studies in animal models and humans. Although the field of neuroepigenomics holds considerable promise, major technical advances are needed to exploit the evolving knowledge for improved understanding of disease pathogenesis and improved therapeutics.",
keywords = "Addiction, Chromatin, Depression, DNA methylation, Epigenetics, Histone acetylation, Histone methylation, Nucleosomes, Transcription",
author = "Greally, {John M.} and Nestler, {Eric J.}",
year = "2016",
month = "6",
day = "21",
doi = "10.1016/B978-0-12-800105-9.00005-6",
language = "English (US)",
isbn = "9780128001059",
pages = "73--91",
booktitle = "Genomics, Circuits, and Pathways in Clinical Neuropsychiatry",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Neuroepigenomics and Human Disease

AU - Greally, John M.

AU - Nestler, Eric J.

PY - 2016/6/21

Y1 - 2016/6/21

N2 - There has been explosive growth in epigenetic research of the nervous system. Epigenetic regulatory processes are believed to mediate mechanisms through which environmental factors exert lifelong changes in the brain and its behavioral output. There is also the possibility that certain types of epigenetic modifications are passed onto offspring and influence their functioning through mechanisms that remain poorly understood. We provide a broader context for these neuroepigenomic questions by highlighting the range of epigenetic mechanisms that are employed by mammalian organisms and current technical challenges in their characterization, and how they contribute to understanding neurological and psychiatric diseases based on studies in animal models and humans. Although the field of neuroepigenomics holds considerable promise, major technical advances are needed to exploit the evolving knowledge for improved understanding of disease pathogenesis and improved therapeutics.

AB - There has been explosive growth in epigenetic research of the nervous system. Epigenetic regulatory processes are believed to mediate mechanisms through which environmental factors exert lifelong changes in the brain and its behavioral output. There is also the possibility that certain types of epigenetic modifications are passed onto offspring and influence their functioning through mechanisms that remain poorly understood. We provide a broader context for these neuroepigenomic questions by highlighting the range of epigenetic mechanisms that are employed by mammalian organisms and current technical challenges in their characterization, and how they contribute to understanding neurological and psychiatric diseases based on studies in animal models and humans. Although the field of neuroepigenomics holds considerable promise, major technical advances are needed to exploit the evolving knowledge for improved understanding of disease pathogenesis and improved therapeutics.

KW - Addiction

KW - Chromatin

KW - Depression

KW - DNA methylation

KW - Epigenetics

KW - Histone acetylation

KW - Histone methylation

KW - Nucleosomes

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=84987851416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987851416&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800105-9.00005-6

DO - 10.1016/B978-0-12-800105-9.00005-6

M3 - Chapter

SN - 9780128001059

SP - 73

EP - 91

BT - Genomics, Circuits, and Pathways in Clinical Neuropsychiatry

PB - Elsevier Inc.

ER -